최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기BioMed research international, v.2018, 2018년, pp.6716547 -
Jeon, Yong-Joon (Department of Biological Sciences, Konkuk University, Neungdong-ro 120, Gwangjin-gu, Seoul 05029, Republic of Korea) , Shin, Jong-Il (Department of Biological Sciences, Konkuk University, Neungdong-ro 120, Gwangjin-gu, Seoul 05029, Republic of Korea) , Lee, Sol (Department of Biological Sciences, Konkuk University, Neungdong-ro 120, Gwangjin-gu, Seoul 05029, Republic of Korea) , Lee, Yoon Gyeong (Department of Biological Sciences, Konkuk University, Neungdong-ro 120, Gwangjin-gu, Seoul 05029, Republic of Korea) , Kim, Ji Beom (Department of Biological Sciences, Konkuk University, Neungdong-ro 120, Gwangjin-gu, Seoul 05029, Republic of Korea) , Kwon, Hak Cheol (Korea Institute of Science and Technology, Gangneung, Gangwondo 25451, Republic of Korea) , Kim, Sung Hun (Korea Institute of Science and Technology, Gangneung, Gangwondo 25451, Republic of Korea) , Kim, Inki (Department of Convergence Medicine, Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Republic of Korea) , Lee, Kyungho (Department of Biological Sciences, Konkuk University, Neungdong-ro 120, Gwangjin-gu, Seoul 05029, Republ) , Han, Ye Sun
Natural products are valuable sources for drug discovery because they have a wide variety of useful chemical components and biological properties. A quick reevaluation of the potential therapeutic properties of established natural products was made possible by the recent development of the methodolo...
1 Arcamone F. Cassinelli G. Fantini G. Adriamycin, 14-hydroxydaimomycin, a new antitumor antibiotic from S. peucetius var. caesius Biotechnology and Bioengineering 1969 11 6 1101 1110 10.1002/bit.260110607 2-s2.0-0014603427 5365804
2 McGowan J. V. Chung R. Maulik A. Piotrowska I. Walker J. M. Yellon D. M. Anthracycline Chemotherapy and Cardiotoxicity Cardiovascular Drugs and Therapy 2017 31 1 63 75 2-s2.0-85011903694 10.1007/s10557-016-6711-0 28185035
3 Rivankar S. An overview of doxorubicin formulations in cancer therapy Journal of Cancer Research and Therapeutics 2014 10 4 853 858 2-s2.0-84921385610 10.4103/0973-1482.139267 25579518
4 Swain S. M. Whaley F. S. Ewer M. S. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials Cancer 2003 97 11 2869 2879 10.1002/cncr.11407 2-s2.0-0038521374 12767102
5 Bao L. Haque A. Jackson K. Increased Expression of P-Glycoprotein Is Associated with Doxorubicin Chemoresistance in the Metastatic 4T1 Breast Cancer Model The American Journal of Pathology 2011 178 2 838 852 10.1016/j.ajpath.2010.10.029 21281816
6 Hess K. R. Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer Journal of Clinical Oncology 2007 24 26 4236 4244 10.1016/S1043-321X(07)80272-4
7 Hiddemann W. Kneba M. Dreyling M. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group Blood 2005 106 12 3725 3732 10.1182/blood-2005-01-0016 2-s2.0-28544435078 16123223
8 Butler M. S. The role of natural product chemistry in drug discovery Journal of Natural Products 2004 67 12 2141 2153 2-s2.0-11344292132 10.1021/np040106y 15620274
9 Kartal M. Intellectual property protection in the natural product drug discovery, traditional herbal medicine and herbal medicinal products Phytotherapy Research 2007 21 2 113 119 10.1002/ptr.2036 2-s2.0-33846973035 17117452
10 Ganesan A. The impact of natural products upon modern drug discovery Current Opinion in Chemical Biology 2008 12 3 306 317 10.1016/j.cbpa.2008.03.016 2-s2.0-44949134801 18423384
11 Li J. W. Vederas J. C. Drug discovery and natural products: end of an era or an endless frontier? Science 2009 325 5937 161 165 10.1126/science.1168243 2-s2.0-67650436176 19589993
12 Sarker S. D. Nahar L. Natural medicine: the genus Angelica Current Medicinal Chemistry 2004 11 11 1479 1500 10.2174/0929867043365189 2-s2.0-2942625958 15180579
13 Zhang J. Li L. Jiang C. Xing C. Kim S.-H. Lü J. Anti-cancer and other bioactivities of Korean Angelica gigas Nakai (AGN) and its major pyranocoumarin compounds Anti-Cancer Agents in Medicinal Chemistry 2012 12 10 1239 1254 2-s2.0-84870231793 10.2174/187152012803833071 22583405
14 Reddy C. Kim S. Hur M. Natural Korean Medicine Dang-Gui: Biosynthesis, Effective Extraction and Formulations of Major Active Pyranocoumarins, Their Molecular Action Mechanism in Cancer, and Other Biological Activities Molecules 2017 22 12 p. 2170 10.3390/molecules22122170
15 Park J. H. Lee Y. J. Keon S. J. Pharmacognostical studies on the Dang Gui from Korea Korean Journal of Pharmacognosy 2005 36 2 141 144 2-s2.0-22144452923
16 Cho S.-K. El-Aty A. M. A. Choi J.-H. Kim M. R. Shim J. H. Optimized conditions for the extraction of secondary volatile metabolites in Angelica roots by accelerated solvent extraction Journal of Pharmaceutical and Biomedical Analysis 2007 44 5 1154 1158 2-s2.0-34547740979 10.1016/j.jpba.2007.03.011 17446029
17 Yoo M. A. Song Y. K. Jang H. Kim D. M. Byun S. Y. Profiling of skin anti-aging related proteins in human dermal fibroblasts by decursin in Angelica gigas Nakai Korean Journal of Chemical Engineering 2011 28 3 880 885 2-s2.0-79952574776 10.1007/s11814-010-0430-1
18 Kim J. H. Jeong S.-J. Kwon H.-Y. Decursin prevents cisplatin-induced apoptosis via the enhancement of antioxidant enzymes in human renal epithelial cells Biological & Pharmaceutical Bulletin 2010 33 8 1279 1284 2-s2.0-77956128489 10.1248/bpb.33.1279 20686219
19 Li L. Li W. Jung S. Lee Y. Kim Y. Protective Effects of Decursin and Decursinol Angelate against Amyloid β -Protein-Induced Oxidative Stress in the PC12 Cell Line: The Role of Nrf2 and Antioxidant Enzymes Bioscience, Biotechnology, and Biochemistry 2014 75 3 434 442 10.1271/bbb.100606
20 Carvalho C. Santos R. X. Cardoso S. Doxorubicin: the good, the bad and the ugly effect Current Medicinal Chemistry 2009 16 25 3267 3285 10.2174/092986709788803312 2-s2.0-70450215499 19548866
21 Pakos‐Zebrucka K. Koryga I. Mnich K. Ljujic M. Samali A. Gorman A. M. The integrated stress response EMBO Reports 2016 17 10 1374 1395 10.15252/embr.201642195 27629041
22 Donnelly N. The eIF2alpha kinases: their structures and functions Cellular and Molecular Life Sciences 2013 70 19 3493 3511 23354059
23 Lu P. D. Harding H. P. Ron D. Translation reinitiation at alternative open reading frames regulates gene expression in an integrated stress response The Journal of Cell Biology 2004 167 1 27 33 2-s2.0-5444264022 10.1083/jcb.200408003 15479734
24 Han J. Kaufman R. J. Physiological/pathological ramifications of transcription factors in the unfolded protein response Genes & Development 2017 31 14 1417 1438 2-s2.0-85028774067 10.1101/gad.297374.117 28860159
25 Han J. Back S. H. Hur J. ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death Nature Cell Biology 2013 15 5 481 490 2-s2.0-84877578475 10.1038/ncb2738 23624402
26 Hanahan D. Weinberg R. A. Hallmarks of cancer: the next generation Cell 2011 144 5 646 674 10.1016/j.cell.2011.02.013 2-s2.0-79952284127 21376230
27 Wong R. S. Y. Apoptosis in cancer: from pathogenesis to treatment Journal of Experimental & Clinical Cancer Research 2011 30 1, article 87 10.1186/1756-9966-30-87 2-s2.0-80053348989
29 Bennett R. L. Carruthers A. L. Hui T. Kerney K. R. Liu X. May W. S. Increased Expression of the dsRNA-Activated Protein Kinase PKR in Breast Cancer Promotes Sensitivity to Doxorubicin PLoS ONE 2012 7 9 2-s2.0-84866636092 10.1371/journal.pone.0046040 e46040 23029376
30 Palmer A. C. Sorger P. K. Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy Cell 2017 171 7 1678 1682.e13 2-s2.0-85038028982 10.1016/j.cell.2017.11.009 29245013
32 Sowndhararajan K. Deepa P. Kim M. Park S. J. Kim S. A Review of the Composition of the Essential Oils and Biological Activities of Angelica Species Scientia Pharmaceutica 2017 85 3 p. 33 10.3390/scipharm85030033
33 Couturier J. Morel M. Pontcharraud R. Interaction of Double-stranded RNA-dependent Protein Kinase (PKR) with the Death Receptor Signaling Pathway in Amyloid β (A β )-treated Cells and in APP The Journal of Biological Chemistry 2010 285 2 1272 1282 10.1074/jbc.M109.041954 19889624
34 Couturier J. Paccalin M. Morel M. Prevention of the β -amyloid peptide-induced inflammatory process by inhibition of double-stranded RNA-dependent protein kinase in primary murine mixed co-cultures Journal of Neuroinflammation 2011 8 1 p. 72 10.1186/1742-2094-8-72
35 Yoon C.-H. Lee E.-S. Lim D.-S. Bae Y.-S. PKR, a p53 target gene, plays a crucial role in the tumor-suppressor function of p53 Proceedings of the National Acadamy of Sciences of the United States of America 2009 106 19 7852 7857 2-s2.0-66049147774 10.1073/pnas.0812148106 19416861
36 Kim S. J. Park K. M. Kim N. Yeom Y. I. Doxorubicin prevents endoplasmic reticulum stress-induced apoptosis Biochemical and Biophysical Research Communications 2006 339 2 463 468 2-s2.0-28444467028 10.1016/j.bbrc.2005.11.040 16298333
37 Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond Nature Reviews Molecular Cell Biology 2012 13 2 89 102 10.1038/nrm3270 2-s2.0-84856111924 22251901
38 Qing G. Li B. Vu A. ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine Deprivation Cancer Cell 2012 22 5 631 644 2-s2.0-84869027086 10.1016/j.ccr.2012.09.021 23153536
39 Armstrong J. L. Flockhart R. Veal G. J. Lovat P. E. Redfern C. P. F. Regulation of endoplasmic reticulum stress-induced cell death by ATF4 in neuroectodermal tumor cells The Journal of Biological Chemistry 2010 285 9 6091 6100 2-s2.0-77949911706 10.1074/jbc.M109.014092 20022965
40 Li Y. Guo Y. Tang J. Jiang J. Chen Z. New insights into the roles of CHOP-induced apoptosis in ER stress Acta Biochimica et Biophysica Sinica 2014 46 8 629 640 10.1093/abbs/gmu048 25016584
41 Xu Z. Bu Y. Chitnis N. Koumenis C. Fuchs S. Y. Diehl J. A. miR-216b regulation of c-Jun mediates GADD153/CHOP-dependent apoptosis Nature Communications 2016 7 p. 11422 10.1038/ncomms11422
42 Safa A. R. Pollok K. E. Targeting the anti-apoptotic protein c-FLIP for cancer therapy Cancers 2011 3 2 1639 1671 10.3390/cancers3021639 2-s2.0-79959736864 22348197
43 Yim N.-H. Lee J. H. Cho W.-K. Yang M. C. Kwak D. H. Ma J. Y. Decursin and decursinol angelate from Angelica gigas Nakai induce apoptosis via induction of TRAIL expression on cervical cancer cells European Journal of Integrative Medicine 2011 3 4 e293 e301 2-s2.0-82455162401
44 McCullough K. D. Martindale J. L. Klotz L. O. Aw T. Y. Holbrook N. J. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bc12 and perturbing the cellular redox state Molecular and Cellular Biology 2001 21 4 1249 1259 10.1128/MCB.21.4.1249-1259.2001 2-s2.0-0035144493 11158311
45 Gotoh T. Terada K. Oyadomari S. Mori M. hsp70-DnaJ chaperone pair prevents nitric oxide- and CHOP-induced apoptosis by inhibiting translocation of Bax to mitochondria Cell Death & Differentiation 2004 11 4 390 402 2-s2.0-1842843854 10.1038/sj.cdd.4401369 14752510
46 Jiang Y. Piao J. Cho H.-J. Kang W.-S. Kim H.-Y. Improvement in antiproliferative activity of Angelica gigas Nakai by solid dispersion formation via hot-melt extrusion and induction of cell cycle arrest and apoptosis in HeLa cells Bioscience, Biotechnology, and Biochemistry 2015 79 10 1635 1643 2-s2.0-84942246789 10.1080/09168451.2015.1046363 26057458
47 Jang J. Jeong S.-J. Kwon H.-Y. Decursin and Doxorubicin Are in Synergy for the Induction of Apoptosis via STAT3 and/or mTOR Pathways in Human Multiple Myeloma Cells Evidence-Based Complementary and Alternative Medicine 2013 2013 13 506324 10.1155/2013/506324
48 Choi H. S. Cho S.-G. Kim M. K. Decursin in Angelica gigas Nakai (AGN) Enhances Doxorubicin Chemosensitivity in NCI/ADR-RES Ovarian Cancer Cells via Inhibition of P-glycoprotein Expression Phytotherapy Research 2016 30 12 2020 2026 2-s2.0-84987653180 10.1002/ptr.5708 27605402
49 Kim J. Yun M. Kim E.-O. Decursin enhances TRAIL-induced apoptosis through oxidative stress mediated- endoplasmic reticulum stress signalling in non-small cell lung cancers British Journal of Pharmacology 2016 173 6 1033 1044 2-s2.0-84960088241 10.1111/bph.13408 26661339
50 Son S. H. Kim M.-J. Chung W.-Y. Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase Cancer Letters 2009 280 1 86 92 2-s2.0-67349245011 10.1016/j.canlet.2009.02.012 19307054
51 Son S. H. Park K.-K. Park S. K. Decursin and decursinol from Angelica gigas inhibit the lung metastasis of murine colon carcinoma Phytotherapy Research 2011 25 7 959 964 2-s2.0-84860397350 10.1002/ptr.3372 21170925
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.